Literature DB >> 9886726

Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992.

D R Murdoch1, M P Love, S D Robb, T A McDonagh, A P Davie, I Ford, S Capewell, C E Morrison, J J McMurray.   

Abstract

AIMS: As heart failure is a syndrome arising from another condition, such as coronary heart disease, it is rarely officially coded as the underlying cause of death regardless of the cause recorded by the physician at the time of certification. We sought to assess the true contribution of heart failure to overall mortality and coronary heart disease mortality and to examine how this contribution has changed over time. METHODS AND
RESULTS: We carried out a retrospective analysis of all death certificates in Scotland between 1979 and 1992 for which heart failure was coded as the underlying or a contributory cause of death. From a total of 833622 deaths in Scotland between 1979 and 1992, heart failure was coded as the underlying cause in only 1.5% (13695), but as a contributory cause in a further 14.3% (126073). In 1979, 28.5% of male and 40.4% of female deaths attributed to coronary heart disease (coded as the underlying cause of death) also had a coding for heart failure. In 1992 these percentages had risen significantly to 34.1% and 44.8%, respectively (both P<0.001). Mortality rates for heart failure as the underlying or contributory cause of death, standardized by age and sex, fell significantly over the period studied in all ages and in both sexes: by 31% in men and 41% in women <65 years and 15.8% in men and 5.1% in women > or =65 years, respectively (P<0.01 for all changes).
CONCLUSIONS: Death from heart failure is substantially underestimated by official statistics. Furthermore, one third or more of deaths currently attributed to coronary heart disease may be related to heart failure and this proportion appears to be increasing. While the absolute numbers of deaths caused by heart failure remains constant, this study is the first to show that standardized mortality rates are declining.

Entities:  

Mesh:

Year:  1998        PMID: 9886726     DOI: 10.1053/euhj.1998.1269

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

1.  Southall And Brent REvisited: Cohort profile of SABRE, a UK population-based comparison of cardiovascular disease and diabetes in people of European, Indian Asian and African Caribbean origins.

Authors:  Therese Tillin; Nita G Forouhi; Paul M McKeigue; Nish Chaturvedi
Journal:  Int J Epidemiol       Date:  2010-11-01       Impact factor: 7.196

2.  In-hospital management of heart failure: in 10 years we have improved, but not enough.

Authors:  Sonia Ferretto; Chiara Dalla Valle; Sonia Cukon Buttignoni; Luca Brugnaro; Giovanni Maria Boffa
Journal:  Intern Emerg Med       Date:  2010-12-09       Impact factor: 3.397

Review 3.  Worldwide risk factors for heart failure: a systematic review and pooled analysis.

Authors:  Shahab Khatibzadeh; Farshad Farzadfar; John Oliver; Majid Ezzati; Andrew Moran
Journal:  Int J Cardiol       Date:  2012-11-30       Impact factor: 4.164

4.  Proportional Mortality due to Heart Failure and Ischemic Heart Diseases in the Brazilian Regions from 2004 to 2011.

Authors:  Eduardo Nagib Gaui; Carlos Henrique Klein; Glaucia Maria Moraes de Oliveira
Journal:  Arq Bras Cardiol       Date:  2016-08-11       Impact factor: 2.000

5.  Feasibility and reproducibility of left ventricular rotation by speckle tracking echocardiography in elderly individuals and the impact of different software.

Authors:  Chloe M Park; Katherine March; Suzanne Williams; Suraj Kukadia; Arjun K Ghosh; Siana Jones; Therese Tillin; Nish Chaturvedi; Alun D Hughes
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

6.  Heart failure--concepts and significance. Birth of a prognostic model.

Authors:  Crina Sinescu; Lucian Axente
Journal:  J Med Life       Date:  2010 Oct-Dec

7.  PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-Grafting.

Authors:  Izabela Wojtkowska; Andrzej Tysarowski; Katarzyna Seliga; Janusz A Siedlecki; Zbigniew Juraszyński; Milosz Marona; Lidia Greszata; Anna Skrobisz; Karol Kaminski; Robert Sawicki; Janina Stępińska
Journal:  PPAR Res       Date:  2014-10-13       Impact factor: 4.964

8.  Redistribution of heart failure as the cause of death: the Atherosclerosis Risk in Communities Study.

Authors:  Michelle L Snyder; Shelly-Ann Love; Paul D Sorlie; Wayne D Rosamond; Carmen Antini; Patricia A Metcalf; Shakia Hardy; Chirayath M Suchindran; Eyal Shahar; Gerardo Heiss
Journal:  Popul Health Metr       Date:  2014-04-10

9.  Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).

Authors:  Ya Zhu Hou; Shuai Wang; Zhi Qiang Zhao; Xian Liang Wang; Bin Li; Shan Bin Soh; Jing Yuan Mao
Journal:  Trials       Date:  2013-05-14       Impact factor: 2.279

10.  Mortality by heart failure and ischemic heart disease in Brazil from 1996 to 2011.

Authors:  Eduardo Nagib Gaui; Gláucia Maria Moraes de Oliveira; Carlos Henrique Klein
Journal:  Arq Bras Cardiol       Date:  2014-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.